Core Cap Advisors, LLC 9 Meters Biopharma, Inc. Transaction History

Core Cap Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$1.0 - $2.57 $101 - $259	101 New	101 $0
Q2 2022 Aug 11, 2022	BUY	$0.26 - $0.64 $522 - $1,286	2,010 New	2,010 $1,000
Q1 2022 Apr 29, 2022	SELL	$0.52 - $1.0 $3,125 - $6,010	-6,010 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$0.85 - $1.33 $5,108 - $7,993	6,010 New	6,010 $6,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Core Cap Advisors, LLC with notifications on news.